As of late, it has definitely been a great time to be an investor in Jazz Pharmaceuticals plc (JAZZ). The stock has moved higher by 28.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider JAZZ’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as JAZZ has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment